Skip to main content

Quantum Materials Corp

MaterialsSan Marcos, TX, USAFounded 2007· One of 955 Materials companies tracked by AMPulse

Develops and manufactures Tetrapod Quantum Dots for medical diagnostics, display lighting, solar cells, and solid-state lighting through patent-pending volume production; also secured 3D printing technology for embedding quantum dots in products for uncopyable anti-counterfeiting identification.

CEO / Founder
Sriram Peruvemba
Team Size
11-50
Stage
Active
Total Funding
$15.5M
Latest Round
Private Equity
Key Investors
Carson Diversified Investments LP; Carson Haysco Holdings LP; Pasaca Capital Inc.

Technology & Products

Key Products

Tetrapod Quantum Dots (TQD) engineered for specific applications; TQD-infused films for medical devices, solid-state lighting, electronic displays, solar cells; 3D-printed quantum dot anti-counterfeiting detection technology; Volume quantum dot production services (from 1 gram to metric tons)

Technological Advantage

Proprietary automated manufacturing achieves economies of scale, uniform color purity, and high quantum yield—addressing the primary limitation competitors face with manual batch processes. 3D-printed quantum dot anti-counterfeiting is patented and difficult to replicate. Acquired Bayer Technology Services quantum dot manufacturing and solar cell patents, strengthening IP position.

Differentiation

Value Proposition

Proprietary automated volume production process enables consistent tetrapod quantum dot quality, scalable cost reduction, and uniform performance—addressing historical limitations of batch synthesis methods. 3D printing anti-counterfeiting application provides secure, uncloneable product identification by embedding quantum dots via additive manufacturing.

How They Differentiate

Automated volume production with consistent yield and color purity vs. competitors' manual batch synthesis. Cadmium-free formulation ahead of regulatory requirements. Unique 3D-printed anti-counterfeiting application with Virginia Tech patent protection. Broader application portfolio spanning medical, display, solar, and lighting vs. competitors focused on single verticals.

Market & Competition

Target Customers

Electronics manufacturers, display makers, solar cell developers, biotech companies, anti-counterfeiting solution providers, medical device manufacturers

Industry Verticals

Medical/biotech (diagnostic assays, drug delivery); Display (LCD, flexible printed electronics); Solar energy (photovoltaic cells); Lighting (LEDs, solid-state lighting); Anti-counterfeiting

Competitors

Nanocrystal Technology Corporation (batch synthesis quantum dots); Nanosys (acquired by Xiaoomi, LCD quantum dot solutions); QD Vision (OLED/display quantum dots)

Growth & Milestones

Growth Metrics

Expanded laboratory facility for research, development, and initial production in Texas; established wholly owned subsidiary Solterra Renewable Technologies for quantum dot solar development; $15M funding round (2021) enabled expanded Tetrapod Quantum Dot production; secured Bayer Technology Services patents; multiple global partnerships (Japan JETRO, Innova Medical); products passed GE, CE, ROHS, PAHS, TüV, REACH certifications.

Major Milestones

Founded January 2007 by Stephen Squires; Secured Virginia Tech 3D printing anti-counterfeiting technology partnership; Acquired Bayer Technology Services quantum dot patents; Established Solterra Renewable Technologies subsidiary (solar focus); Launched QMC HealthID with Innova Medical Group partnership; $15M private equity round from Pasaca Capital (February 2021); Established expanded laboratory facility in Texas for volume production; Solterra-JETRO partnership for Japan market introduction

Notable Customers

Leading LCD/display manufacturers (using cadmium-free TQD for compliance); Quantum dot solar cell research teams; Biotech companies developing diagnostic assays and drug delivery; Medical device manufacturers (TQD-infused films for diagnostic applications)

https://www.qmcdots.com

Why this company matters

Quantum Materials develops tetrapod quantum dots (TQDs) using a proprietary automated volume production process that addresses the inconsistency and scalability limits of manual batch synthesis. The company's cadmium-free TQDs achieve uniform color purity and high quantum yield, targeting regulatory compliance ahead of heavy-metal restrictions. Its technology spans multiple end markets, including LCD displays, solid-state lighting, photovoltaic cells, and medical diagnostic assays.

Beyond conventional quantum dot applications, Quantum Materials has developed a 3D printing process that embeds TQDs into products during additive manufacturing for anti-counterfeiting. Developed with Virginia Tech's DREAMS Laboratory, the patented method creates uncloneable identification markers readable under specific light. This positions the company in the security-printing niche alongside its core materials business.

The company serves electronics manufacturers, display makers, solar cell developers, and biotech firms. Notable partnerships include Innova Medical Group for the QMC HealthID diagnostic test and JETRO for introducing quantum dot solar technology to Japan. Quantum Materials also acquired Bayer Technology Services' quantum dot manufacturing and solar cell patents, strengthening its IP portfolio. Competitors include Nanosys and QD Vision, which focus primarily on display applications, while Quantum Materials maintains a broader vertical reach.

A $15 million funding round in 2021 from Pasaca Capital supported expanded TQD production capacity. The company's automated process and cadmium-free formulation provide differentiation, but scaling from lab to metric-ton production and competing with established display supply chains remain open questions.